Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Sarcoma 17Osteosarcoma 6Neuroectodermal Tumors, Primitive, Peripheral 4Wilms Tumor 3Rhabdoid Tumor 3Hepatoblastoma 3Vomiting 2Sarcoma, Ewing 2Rhabdomyosarcoma 2Retinoblastoma 2Neuroblastoma 2Neoplasms, Germ Cell and Embryonal 2Neoplasms 2Nausea 2Melanoma 2Medulloblastoma 2Lymphoma 2Dendritic Cell Sarcoma, Interdigitating 2Central Nervous System Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Burkitt Lymphoma 2Stomach Neoplasms 1Sarcoma, Myeloid 1Sarcoma, Clear Cell 1Recurrence 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Optic Nerve Glioma 1

Interventions

dexamethasone acetate 2Vincristine 2Mesna 2Ifosfamide 2Doxorubicin 2Dexamethasone 2Calcium Dobesilate 2fosaprepitant 1Palonosetron 1Ondansetron 1Octreotide 1Electroacupuncture 1Dexrazoxane 1Cyproheptadine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Vomiting × Mesna × Sarcoma × Clear all
NCT01490060 2016-04-11

Fosaprepitant in Patients Receiving Ifosfamide-based Regimen

M.D. Anderson Cancer Center

Phase NA Completed
47 enrolled 6 charts
Sarcoma

Nausea, Neoplasms, Sarcoma, Vomiting

NCT00410488 2013-03-22

Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)

M.D. Anderson Cancer Center

Phase NA Completed
51 enrolled 5 charts
Sarcoma

Nausea, Sarcoma, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡